Supply/Disclosures
Ogdie A. Utilizing Private Technology to Observe and Enhance Outcomes in Inflammatory Arthritis. Introduced at: Interdisciplinary Autoimmune Summit; July 10-12, 2020 (digital assembly).
Disclosures:
Ogdie experiences consulting for AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Corrona, Janssen, Lilly, Novartis Prescription drugs, Pfizer, Takeda Pharmaceutical Firm and UCB; grant funding from Novartis Prescription drugs (to Penn), Pfizer (to Penn), Amgen (to Ahead/NDB); and royalties (to husband) from Novartis Prescription drugs.
Fast growth of private applied sciences might result in improved outcomes however extra challenges for the clinical and analysis communities coping with conditions like inflammatory arthritis, based on a presenter at the 2020 Interdisciplinary Autoimmune Summit.
Alexis Ogdie, MD, MSCE, affiliate professor of medication and epidemiology at the Perelman Faculty of Medication at the College of Pennsylvania, addressed what she referred to as the “new regular” of the COVID-19 period because it pertains to non-public technology. “Many of us are simply getting again to seeing sufferers in the workplace,” she mentioned. “That was the previous regular. The brand new regular is utilizing private technology.”
Fast growth of private applied sciences might result in improved outcomes however extra challenges for the clinical and analysis communities coping with circumstances like inflammatory arthritis, based on a presenter at IAS 2020.
Ogdie aimed to debate how all the pieces from smartphone telemedicine visits to wearable health outcome trackers can be utilized to leverage improved well being care behaviors and outcomes in sufferers with immune-mediated circumstances.
She broke this method down into six parts, together with distant monitoring, understanding the issues, delivering interventions, reviewing self-directed suggestions and interactions, predicting outcomes and providing route for analysis. Furthermore, the dialogue was framed in the context of the so-called 5,000-hour downside.
Alexis Ogdie
“A affected person comes in to see us for a 15-minute or half-hour go to,” Ogdie mentioned. “Then they arrive see us in three months or 6 months. Take into consideration all these hours in between these two factors in care.”
In that meantime, technology could also be used to validate or refine patient-reported info. For instance, actigraphs used to measure sleep in patients with RA present complementary info to patient-reported outcomes.
Utilizing information from these actigraphs, clinicians can then tailor interventions utilizing a Fitbit or different wearable gadget. Clinicians could make use of all the pieces from social norms to rewards to assist sufferers change behaviors and attain objectives. As well as, the gadget can present real-time suggestions to the affected person to encourage continuation of the intervention and knowledge that clinicians might use to make needed modifications or tweaks.
Regardless of these benefits, Ogdie harassed that wearables have their limitations. “You must really put on them, and cost them, and sync them,” she mentioned.
Price may be problematic for a lot of sufferers. “Setup just isn’t all the time intuitive,” Ogdie added. “Inter-device correlation may be low however intra-device correlation tends to be fairly good.”
The problems lengthen to the beauty. “The actually good research-grade ones are ugly and that issues to sufferers,” Ogdie mentioned.
Ogdie added that over- and under-estimation of the efficacy of wearable applied sciences is feasible. Nonetheless, she harassed that many of these limitations have all the time been limitations for technology in medication, together with poor high quality, poor battery life and design points. As well as, clinicians and sufferers alike could also be uncomfortable with the technology.
Authentication may also be a problem, as can system integration.
The connection between the gadget and the affected person inhabitants have to be thought of, as should safety and HIPAA compliance.
Regardless of these considerations, there isn’t any doubt that wearable technology is right here to remain, doubtless even in the post-COVID period, when in-patient visits can turn out to be regular once more. “COVID has taught us loads about the way to work together with sufferers nearly,” Ogdie mentioned. “I hope that the new regular will probably be that linked well being is a component of our day-to-day administration of sufferers.”
Interdisciplinary Autoimmune Summit
Comments
Post a Comment